logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Pharmacogenomic dosing shows promise in gastroesophageal adenocarcinoma

The strategy could be especially appropriate with baseline or high risk for peripheral neuropathy.